A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Orforglipron
Related studies linked through entity extraction aliases.
A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
- Status
- COMPLETED
- Phase
- PHASE1
A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
- Status
- COMPLETED
- Phase
- PHASE3
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
- Status
- COMPLETED
- Phase
- PHASE3